下载掌阅APP，畅读海量书库
立即打开
［1］LOTAN Y，ROEHRBORN C G.Sensitivity and specificity of commonly available bladder tumor markers versus cytology：results of a comprehensive literature review and meta-analyses［J］.Urology，2003，61（1）：109-118；discussion 118.
［2］PAIK M L，SCOLIER M J，BROWN S L，et al.Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy［J］.J Urol，2000，163（6）：1693-1696.
［3］GLAS A S，ROOS D，DEUTEKOM M，et al.Tumor markers in the diagnosis of primary bladder cancer.A systematic review［J］.J Urol，2003，169（6）：1975-1982.
［4］BEREZNEY R，COFFEY D S.Identification of a nuclear protein matrix［J］.Biochem Biophys Res Commun，1974，60（4）：1410-1417.
［5］JAMSHIDIAN H，KOR K，DJALALI M，et al.Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder［J］.Urol J，2008，5（4）：243-247.
［6］MOWATT G，ZHU S，KILONZO M，et al.Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers（FISH，ImmunoCyt，NMP22）and cytology for the detection and follow-up of bladder cancer［J］.Health Technol Assess，2010，14（4）：1-331，iii-iv.
［7］DEGTYAR P，NEULANDER E，ZIRKIN H，et al.Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder［J］.Urology，2004，63（2）：398-401.
［8］LUO B，LI W，DENG C H，et al.Utility of fluorescence in situ hybridization in the diagnosis of upper urinary tract urothelial carcinoma［J］.Cancer Genet Cytogenet，2009，189（2）：93-97.
［9］O'SULLIVAN P，SHARPLES K，DALPHIN M，et al.A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria［J］.J Urol，2012，188（3）：741-747.
［10］JEONG S，PARK Y，CHO Y，et al.Diagnostic values of urine CYFRA21-1，NMP22，UBC，and FDP for the detection of bladder cancer［J］.Clin Chim Acta，2012，414：93-100.
［11］ALLORY Y，BEUKERS W，SAGRERA A，et al.Telomerase reverse transcriptase promoter mutations in bladder cancer：high frequency across stages，detection in urine，and lack of association with outcome［J］.Eur Urol，2014，65（2）：360-366.
［12］MIYAKE M，SUGANO K，SUGINO H，et al.Fibroblast growth factor receptor 3 mutation in voided urine is a useful diagnostic marker and significant indicator of tumor recurrence in non-muscle invasive bladder cancer［J］.Cancer Sci，2010，101（1）：250-258.
［13］REINERT T，BORRE M，CHRISTIANSEN A，et al.Diagnosis of bladder cancer recurrence based on urinary levels of EOMES，HOXA9，POU4F2，TWIST1，VIM，and ZNF154hypermethylation［J］.PLoS One，2012，7（10）：e46297.
［14］GOODISON S，CHANG M，DAI Y，et al.A multi-analyte assay for the non-invasive detection of bladder cancer［J］.PLoS One，2012，7（10）：e47469.
［15］ROSSER CJ，CHANG M，DAI Y，et al.Urinary protein biomarker panel for the detection of recurrent bladder cancer［J］.Cancer Epidemiol Biomarkers Prev，2014，23（7）：1340-1345.